The Real Psychedelic Bottleneck Is Coverage
T Wagner, Gaetano Lardieri, Nichelle Santos, Jessica Umlauf, Vaughn Wagner At PhilaDelic 2025, the most consequential question was not whether psychedelics can help people. It was whether U.S. healthcare can recognize, reimburse, and safely scale the kind of care these treatments actually require. The molecule is rarely the bottleneck. The bottleneck is coverage: the administrative, […]


